Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Do You Have a Position in Ryan Specialty? Here's the Essential Facts.

Shares of Ryan Specialty have moved -1.9% today, and are now trading at a price of $57.25. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 397,539 compared to the stock's average volume of 1,628,755.

Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, and Singapore. Based in Chicago, United States the company has 5,982 full time employees and a market cap of $15,139,110,912. Ryan Specialty currently offers its equity investors a dividend that yields 0.8% per year.

The company is now trading -13.95% away from its average analyst target price of $66.53 per share. The 15 analysts following the stock have set target prices ranging from $60.0 to $76.0, and on average give Ryan Specialty a rating of buy.

Over the last 12 months RYAN shares have declined by -21.4%, which represents a difference of -34.0% when compared to the S&P 500. The stock's 52 week high is $77.16 per share and its 52 week low is $50.08. With its net margins declining an average -11.8% over the last 4 years, Ryan Specialty declining profitability gives us reason to believe its stock price will continue to underwhelm.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2024 2,515,710 94,665 4 33.33
2023 2,077,549 61,037 3 -25.0
2022 1,725,193 61,052 4 -20.0
2021 1,432,771 65,873 5 -28.57
2020 1,018,274 68,104 7 -12.5
2019 765,111 64,166 8
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS